(Q37402525)

20 August 2017

1 reference

title

Immunological risk of injectable drug delivery systems (English)

1 reference

20 August 2017

1 reference

1 reference

1

Wim Jiskoot

1 reference

20 August 2017

Rianne M F van Schie

2

1 reference

20 August 2017

Myrra G Carstens

series ordinal

3

1 reference

20 August 2017

Huub Schellekens

series ordinal

4

1 reference

20 August 2017

publication date

27 February 2009

1 reference

20 August 2017

published in

Pharmaceutical Research

1 reference

20 August 2017

volume

26

1 reference

20 August 2017

issue

6

1 reference

20 August 2017

page(s)

1303-1314

1 reference

Interaction between phosphatidylserine and the phosphatidylserine receptor inhibits immune responses in vivo

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11095-009-9855-9

Determinants of autoantibody induction by conjugated papillomavirus virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-009-9855-9

Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-009-9855-9

21 January 2018

Liposome opsonization

1 reference

https://api.crossref.org/works/10.1007%2FS11095-009-9855-9

Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-009-9855-9

HPMA copolymer-modified avidin: immune response

21 January 2018

1 reference

12 December 2020

Role of complement activation in hypersensitivity reactions to doxil and hynic PEG liposomes: experimental and clinical studies

1 reference

12 December 2020

Protein instability in poly(lactic-co-glycolic acid) microparticles.

1 reference

12 December 2020

Anaphylaxis: lessons from mouse models

1 reference

12 December 2020

Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase

1 reference

12 December 2020

Platelets as immune cells: bridging inflammation and cardiovascular disease

1 reference

12 December 2020

Platelet‐activating factor receptor and signal transduction mechanisms 1

1 reference

12 December 2020

Contribution of complement system on destabilization of liposomes composed of hydrogenated egg phosphatidylcholine in rat fresh plasma

1 reference

12 December 2020

Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies.

1 reference

12 December 2020

Starlike vs. classic macromolecular prodrugs: two different antibody-targeted HPMA copolymers of doxorubicin studied in vitro and in vivo as potential anticancer drugs

1 reference

12 December 2020

Unusual electrostatic effects on binding of C1q to anionic liposomes: role of anionic phospholipid domains and their line tension

1 reference

12 December 2020

Biodegradable microspheres. III: some immunological properties of polyacryl starch microparticles

1 reference

12 December 2020

Antibodies to cholesterol, cholesterol conjugates and liposomes: implications for atherosclerosis and autoimmunity

1 reference

12 December 2020

Liposome-mediated triggering of complement cascade

1 reference

12 December 2020

Hypersensitivity and loss of disease site targeting caused by antibody responses to PEGylated liposomes

1 reference

12 December 2020

PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner

1 reference

12 December 2020

Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes

1 reference

12 December 2020

Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles

1 reference

12 December 2020

The influence of antigen organization on B cell responsiveness

1 reference

12 December 2020

Antibodies to lipids and liposomes: immunology and safety.

1 reference

12 December 2020

Mannose-targeted systems for the delivery of therapeutics

1 reference

12 December 2020

Gangliosides elicit a T-cell independent antibody response

1 reference

12 December 2020

Immunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomes

1 reference

12 December 2020

Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection.

1 reference

12 December 2020

Immunomodulating activities of soluble synthetic polymer-bound drugs

1 reference

12 December 2020

Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis

1 reference

12 December 2020

Influence of the physicochemical properties of liposomes on the accelerated blood clearance phenomenon in rats.

1 reference

12 December 2020

Hemodynamic changes induced by liposomes and liposome-encapsulated hemoglobin in pigs: a model for pseudoallergic cardiopulmonary reactions to liposomes. Role of complement and inhibition by soluble CR1 and anti-C5a antibody

1 reference

12 December 2020

Bioequivalence and the immunogenicity of biopharmaceuticals

1 reference

12 December 2020

Complement activation in human serum by liposome-encapsulated hemoglobin: the role of natural anti-phospholipid antibodies

1 reference

12 December 2020

Induction and detection of antibodies to squalene

1 reference

12 December 2020

The immunogenicity of soluble haptenated polymers is determined by molecular mass and hapten valence

1 reference

12 December 2020

Antibodies induced by liposomal protein exhibit dual binding to protein and lipid epitopes.

1 reference

12 December 2020

Blood compatibility of cetyl alcohol/polysorbate-based nanoparticles

1 reference

12 December 2020

Artificial viruses: a nanotechnological approach to gene delivery

1 reference

12 December 2020

Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution

1 reference

12 December 2020

Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes

1 reference

12 December 2020

Antigenicity of fullerenes: antibodies specific for fullerenes and their characteristics

1 reference

12 December 2020

Methylation of the phosphate oxygen moiety of phospholipid-methoxy(polyethylene glycol) conjugate prevents PEGylated liposome-mediated complement activation and anaphylatoxin production

1 reference

12 December 2020

Repeated injections of PEG-PE liposomes generate anti-PEG antibodies.

1 reference

12 December 2020

An immune response to ovalbumin covalently coupled to liposomes is prevented when the liposomes used contain doxorubicin

1 reference

12 December 2020

1 reference

12 December 2020

Phosphatidylserine containing liposomes reduce immunogenicity of recombinant human factor VIII (rFVIII) in a murine model of hemophilia A.

1 reference

12 December 2020

Passive transfer of polyethylene glycol to liposomal-recombinant human FVIII enhances its efficacy in a murine model for hemophilia A.

1 reference

12 December 2020

Nanoparticle-induced platelet aggregation and vascular thrombosis

1 reference

12 December 2020

Nanoparticles and microparticles as vaccine-delivery systems

1 reference

12 December 2020

Assessment of thrombogenic potential of liposomes

1 reference

12 December 2020

Drug delivery systems: entering the mainstream

1 reference

12 December 2020

Antibodies to cholesterol: biological implications of antibodies to lipids

1 reference

12 December 2020

In vivo applications of PEG liposomes: unexpected observations

1 reference

12 December 2020

Liposomal meningococcal B vaccination: role of dendritic cell targeting in the development of a protective immune response.

1 reference

12 December 2020

Neutralizing antiviral B cell responses

1 reference

12 December 2020

Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives

1 reference

12 December 2020

Novel uses for anti-platelet agents as anti-inflammatory drugs.

1 reference

12 December 2020

An overview of the immune system

1 reference

12 December 2020

Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer.

1 reference

12 December 2020

Complement activation by core-shell poly(isobutylcyanoacrylate)-polysaccharide nanoparticles: influences of surface morphology, length, and type of polysaccharide.

1 reference

12 December 2020

T cell independent antigens

1 reference

12 December 2020

HPMA copolymer-anticancer drug conjugates: design, activity, and mechanism of action

1 reference

12 December 2020

Physicochemical and biological characterization of targeted, nucleic acid-containing nanoparticles

1 reference

12 December 2020

Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients

1 reference

12 December 2020

Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions

1 reference

12 December 2020

Picogram quantities of anti-Ig antibodies coupled to dextran induce B cell proliferation

1 reference

12 December 2020

The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes.

1 reference

12 December 2020

Electrostatic interactions and complement activation on the surface of phospholipid vesicle containing acidic lipids: effect of the structure of acidic groups

1 reference

12 December 2020

Serum opsonins and liposomes: their interaction and opsonophagocytosis

1 reference

12 December 2020

Analysis of C3 deposition and degradation on bacterial surfaces after opsonization

1 reference

12 December 2020

Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity

1 reference

12 December 2020

Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes.

1 reference

12 December 2020

Time-dependent changes in opsonin amount associated on nanoparticles alter their hepatic uptake characteristics

1 reference

12 December 2020

Immunological properties of engineered nanomaterials

1 reference

12 December 2020

B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms

1 reference

12 December 2020

Serum-mediated recognition of liposomes by phagocytic cells of the reticuloendothelial system - The concept of tissue specificity

1 reference

12 December 2020

Structure-immunogenicity relationships of therapeutic proteins

1 reference

12 December 2020

Anti-liposome antibodies induced by lipid A. I. Influence of ceramide, glycosphingolipids, and phosphocholine on complement damage.

1 reference

12 December 2020

Functions of toll-like receptors: lessons from KO mice

1 reference

12 December 2020

Tumour-targeted nanomedicines: principles and practice.

1 reference

12 December 2020

Factors affecting the clearance and biodistribution of polymeric nanoparticles.

1 reference

12 December 2020

Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer.

1 reference

12 December 2020

Novel approaches to vaccine delivery

1 reference

12 December 2020

Accelerated blood clearance of PEGylated liposomes upon repeated injections: effect of doxorubicin-encapsulation and high-dose first injection

1 reference

12 December 2020

Complement activation-related pseudoallergy caused by amphiphilic drug carriers: the role of lipoproteins

1 reference

12 December 2020

Sheddable coatings for long-circulating nanoparticles

1 reference

12 December 2020

Production of antibodies against phosphocholine, phosphatidylcholine, sphingomyelin, and lipid A by injection of liposomes containing lipid A

1 reference

12 December 2020

Synthesis and characterization of PLGA nanoparticles

1 reference

12 December 2020

Immunogenicity of N-(2-hydroxypropyl)-methacrylamide copolymers--potential hapten or drug carriers

1 reference

12 December 2020

Immunogenicity and rapid blood clearance of liposomes containing polyethylene glycol-lipid conjugates and nucleic Acid

1 reference

12 December 2020

Immunons revisited: binding of multivalent antigens to B cells

1 reference

12 December 2020

Immunization with cholesterol-rich liposomes induces anti-cholesterol antibodies and reduces diet-induced hypercholesterolemia and plaque formation

1 reference

12 December 2020

Induction of systemic antitumour resistance with targeted polymers

1 reference

12 December 2020

Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes

1 reference

12 December 2020

Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles

1 reference

12 December 2020

Antibodies to cholesterol

1 reference

12 December 2020

Long-circulating and target-specific nanoparticles: theory to practice

1 reference

12 December 2020

The binding of phosphatidylglycerol liposomes to rat platelets is mediated by complement

1 reference

12 December 2020

Cholesterol-dependent human complement activation resulting in damage to liposomal model membranes.

1 reference

12 December 2020

Molecular determinants of immunogenicity: the immunon model of immune response

1 reference

12 December 2020

Liposomes: From the Bench to the Bed

1 reference

12 December 2020

Regulating inflammation through the anti-inflammatory enzyme platelet-activating factor-acetylhydrolase

1 reference

12 December 2020

Recent advances in the discovery and delivery of vaccine adjuvants

1 reference

12 December 2020

Animal models of complement-mediated hypersensitivity reactions to liposomes and other lipid-based nanoparticles

1 reference

12 December 2020

Nanotechnological approaches for the delivery of macromolecules

1 reference

12 December 2020

The role of metabolism in the immunogenicity of drugs: production of antibodies to a horseradish peroxidase generated conjugate paracetamol

1 reference

12 December 2020

T helper cell-independent neutralizing B cell response against vesicular stomatitis virus: role of antigen patterns in B cell induction?

1 reference

12 December 2020

The role of hepatocytes in the clearance of liposomes from the blood circulation

1 reference

12 December 2020

Toxicity screening of liposomes

1 reference

12 December 2020

Dextran-conjugated anti-Ig antibodies as a model for T cell-independent type 2 antigen-mediated stimulation of Ig secretion in vitro. I. Lymphokine dependence

1 reference

12 December 2020

Nanovehicular intracellular delivery systems

1 reference

12 December 2020

Nanosystems for simultaneous imaging and drug delivery to T cells

1 reference

12 December 2020

Immunogenicity of immunoliposomes: reactivity against species-specific IgG and liposomal phospholipids

1 reference

12 December 2020

Trends and developments in liposome drug delivery systems

1 reference

12 December 2020

The contribution of phagocytic activity of liver macrophages to the accelerated blood clearance (ABC) phenomenon of PEGylated liposomes in rats

1 reference

12 December 2020

Activation of human complement by liposomes: a model for membrane activation of the alternative pathway

1 reference

12 December 2020

Analysis of B cell activation requirements with TNP-conjugated polyacrylamide beads

1 reference

12 December 2020

The role of immunoproteins in the survival of liposomes in the circulation.

1 reference

12 December 2020

The influence of virus structure on antibody responses and virus serotype formation

1 reference

12 December 2020

ANTIBODIES REACTING WITH STEROID HAPTENS

1 reference

12 December 2020

10.1007/S11095-009-9855-9

Identifiers

DOI

1 reference

20 August 2017

1 reference